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1  Introduction
Epilepsy is a major focus of research on neurological 
disorders. The incidence of epilepsy in the general 
population is about 45/100 000, its prevalence rate is 0.5% 
and lifetime probability of a seizure is approximately 
3%[1]. Administration of kainic acid (KA), an excitotoxic 
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substance, could stimulate glutamate receptors, thus 
increasing the levels of reactive oxygen species (ROS) 
and glutaminergic activity[2]. Oxidative stress has 
been reported to be a possible molecular mechanism 
of KA-induced neurotoxicity and it is associated with 
hippocampal cell death[3,4]. Both systemic and intracerebral 
injection of KA have been shown to trigger epileptiform 
seizures by damaging the CA3 region of the hippocampus; 
these KA-induced seizures have been shown to propagate 
to other limbic structures and demonstrate a pattern of 
cell death similar to that of temporal lobe epilepsy[5]. 
Furthermore, increases in mitochondrial superoxide 
production and hippocampal neuronal loss caused by 
KA have been shown to be attenuated in transgenic mice 
overexpressing mitochondrial superoxide dismutase-2[6]. 
KA induces activation of nuclear factor-kappa B (NF-
κB) in degenerating neurons within 24 h of treatment[7]. 
Similarly, the role of antioxidants has been established in 
inhibiting seizures caused by excitotoxic agents[2,8]. 
Rutin (quercetin-3-O-rutinoside), a flavonoid, is found 
in many plants such as buckwheat, passion flower, apple, 
tea and Ginkgo biloba[9-11]. Rutin has been found to have 
neuroprotective effects in several different memory 
impairment models[12-14], and in cerebral ischemia[15,16]. In 
this study, we investigated the possible effects of rutin on 
oxidative stress in KA-induced seizure in mice. Moreover, 
malondialdehyde (MDA) and thiol were measured as 
indicators of lipid peroxidation and oxidative stress, 
respectively, in the early and late phases after KA-induced 
seizures. 
2  Materials and methods
2.1  Animals
A total of 36 male BALB/c mice (body weight 20 to 
25 g) were obtained from the Razi Institute (Karaj, Iran) 
and housed in groups of four per cage under standard 
laboratory conditions. They were maintained at constant 
room temperature (21 °C ± 2 °C) under a 12:12 h light-
dark cycle with free access to food and water. All 
animal experiments were performed in accordance with 
the European Communities Council Directive of 24 
November 1986 (86/609/EEC) so as to minimize the 
number of animals used and their suffering. 
2.2  Drugs
Rutin and KA were purchased from Sigma (St Louis, 
MO, USA). Other drugs used in this study included 
xylazine (Loughrea, Co. Galway, Ireland) and ketamine 
(Rotexmedica, GmbH, Germany). Rutin (8.3 mg/mL) and 
KA (0.5 mg/mL) were dissolved in saline. Other reagents 
included 2,2′-dinitro-5,5′-dithiodibenzoic acid (DTNB), 
2-thiobarbituric acid (TBA), Tris (Trizma® base), sodium 
ethylenediaminetetraacetic acid (NA EDTA), methanol, 
and trichloroacetic acid (TCA). 
2.3  KA administration and experimental design 
The pH of KA solution was adjusted to 7.2 to 7.4 
with NaOH[17]. Mice were divided into three groups of 
12 animals each. The control group was given an intra-
peritoneal (i.p.) injection of saline (10 mL/kg) daily for 
7 d, and on the last day, KA (10 mg/kg, i.p.) was injected 
30 min after administration of saline. In the two treatment 
groups, rutin (100 and 200 mg/kg, i.p.) was administered 
daily for 7 d, and on the last day, KA (10 mg/kg, i.p.) was 
injected 30 min after administration of rutin[18]. Following 
administration of KA, mice were observed for behavioural 
changes over a period of 2 h. The behavioural scores were 
as follows: 0, no response; 1, immobility; 2, rigid posture; 
3, scratching/circling/head bobbing; 4, forelimb clonus/
rearing/falling; 5, repetitive pattern of 4; and 6, severe 
tonic-clonic seizures[19]. Also, onset and number of wet-
dog shake (WDS), which is characteristic behavioural 
response[20,21], was counted for 2 h after i.p. injection of 
KA[22]. 
Finally, 1 and 21 d after KA administration, mice were 
anaesthetized with i.p. injection of ketamine (100 mg/mL, 
60 mg/kg)/xylazine (20 mg/mL, 6 mg/kg) and sacrificed. 
The hippocampi of animals were immediately removed, 
cleaned with chilled saline (0.9%) and used for biochemical 
analysis. 
2.4  Measurement of lipid peroxidation
MDA level of hippocampi was measured spectro-
photometrically. MDA reacts with TBA as a thiobarbituric 
acid reactive substance (TBARS) to produce a red 
coloured complex that has a peak absorbance at 535 nm[23]. 
Hippocampus was homogenized with cold 1.5% KCl 
(15 mg/mL) to make a 10% homogenate. To 1.0 mL of 
the hippocampus homogenate, 2.0 mL of TCA-TBA-
HCl was added and mixed thoroughly. The solution was 
heated for 60 min in a boiling water bath. After cooling, 
the flocculent precipitate was removed by centrifugation 
at 1 000 × g for 10 min. The absorbance at 535 nm 
was measured by Genesys 10 UV-Spectrophotometer 
(Spectronic Unicam, Model, Rochester, NY, USA) against 
a blank (TBA, 1 mL) that contained all the reagents except 
the sample. The amount of MDA equivalents formed was 
calculated using a molar extinction coefficient of 1.56 × 
105/mol·cm and expressed as nmol MDA equivalents/mg 
protein.
2.5  Measurement of total thiol 
Total thiol was measured using DTNB. This reagent 
reacts with the thiol to produce a yellow-coloured complex 
that has a peak absorbance at 412 nm[24]. Briefly, 1 mL Tris-
EDTA buffer (0.25 mol/L Tris; 2 mmol/L EDTA; pH 8.6) 
was added to 50 μL hippocampus homogenate in the 2-mL 
cuvettes. Sample absorbance was read at 412 nm against 
Tris-EDTA buffer alone (A1). Next, 20 μL of DTNB 
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(10 mmol/L in methanol, purity ≥99.5%) was added 
to the mixture, and after 15 min (stored at laboratory 
temperature), the sample absorbance was read again (A2). 
The absorbance of the DTNB reagent was read as a blank 
(B)[25]. Total thiol concentration (mmol/L) was calculated 
from the following equation: total thiol concentration 
(mmol/L) = (A2− A1 − B) × (1.07/0.05) × 13.6 and 
expressed as nmol MDA equivalents/mg protein.
2.6  Data analysis
Seizure score, time of onset, number of WDS, MDA 
level and thiol concentration were expressed as mean ± 
standard error of mean. Differences among experimental 
groups were analysed by one-way analysis of variance 
(ANOVA), and the post-hoc Tukey’s test was used for 
multiple comparisons (Prism software ver 3.0). Also, 
we used two-way ANOVA to investigate the interaction 
between the effects of treatment and test day. P < 0.05 
was considered to be statistically significant.
3  Results
3.1  Effects of KA on seizure
Seizure scores in the rutin-pretreated groups were 
significantly lower than those in the control group 
(F (2,33) = 31.9, P < 0.01; Figure 1A). The delay to 
onset of WDS increased significantly in the rutin groups 
compared to that in the control group (F (2,33) =13.6, P < 
0.01; Figure 1B). During the 2-hour observation period 
after KA administration, the number of WDS in the rutin 
groups was significantly lower than that in the control 
group (F (2,33) = 5.8, P < 0.05; Figure 1 C). 
3.2  TBARS measurement
Pretreatment with rutin significantly decreased MDA 
levels in the hippocampus at doses of 100 and 200 mg/kg 
compared to the control group on day 1 (F (2,15) = 7, P < 
0.05, P < 0.01, respectively; Figure 2). Furthermore, MDA 
level in the rutin groups was significantly lower than that 
in the control group on day 21 (F (2,15) = 5.3, P < 0.05; 
Figure 2). 
There was no interaction between the effects of treatment 
and test day (P>0.2, two-way ANOVA).
3.3  Total thiol assay
The content of thiol in the hippocampus of the rutin-
treated (100 and 200 mg/kg) groups was significantly 
higher than that of the control group on day 1 (n=6, F (2, 
15) = 9.2, P < 0.01, respectively; Figure 3). However, 
there was no significant elevation in the total content of 
thiol in the hippocampus of the rutin groups compared to 
that of the control group on day 21 (n=6, F(2,15) = 4.4, 
P > 0.05; Figure 3). Two-way ANOVA showed that the 
interaction between the effects of treatment and test day 
was not significant (P > 0.285).
4  Discussion
In the present study, we investigated the possible effects 
of rutin on oxidative stress in KA-induced seizure in mice. 
Pretreatment with rutin dose-dependently reduced the 
seizure score relative to control animals. 
Another significant finding in the present study is that 
rutin pretreatment was able to significantly and dose-
dependently decrease the KA-evoked WDS that is 
characteristic of experimental convulsive seizures[26]. 
The KA-induced WDS represents neuronal hyperactivity 
in limbic structures that spread to midbrain areas and to 
the motor system[21]. Interestingly, an increased number 
of γ-aminobutyric acid (GABA) receptors has also been 
reported after limbic stimulation[27], suggesting that the 
WDS is a sign of the progression of limbic seizures 
towards generalized seizure[26]. The present data indicate 
Figure 1  The effects of rutin (100 and 200 mg/kg) on seizure score (A), onset of WDS (B) and the number of WDS (C) in mice with 
KA-induced seizure
The control group was administered saline (i.p.) for 7 d, and on the last day, KA (10 mg/kg, i.p.) was injected 30 min after administration of saline. 
Rutin (100 and 200 mg/kg, i.p.) was administered for 7 d, and on the last day KA (10 mg/ kg, i.p.) was injected 30 min after the administration of 
rutin. Data are expressed as mean ± standard error of mean. *P < 0.05, **P < 0.01, vs control group, n=36, analyzed by post-hoc Tukey’s test.
KA: kainic acid; WDS: wet-dog shake.
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that rutin, activated by the GABAergic system, could 
prevent neuronal hyperactivity in specific regions of the 
brain.
In our previous studies, rutin demonstrated potential 
anticonvulsant effects in pentylenetetrazol (PTZ)-induced 
acute and chronic seizures in rats[28,29]. It has also been 
reported that many flavonoids are ligands for GABAA 
receptors in the central nervous system[30,31]. Thus, the 
same GABAergic system may have contributed to the 
anticonvulsant effects of rutin in the present work.
Monitored in the hippocampus, MDA levels of both 
rutin groups were significantly lower than those of the 
control group on days 1 and 21 of the present study. 
It seems that the effect of rutin on day 1 was dose-
dependent. However, this effect was not dose-dependent 
on day 21. In addition, the total content of thiol in both 
rutin groups on day 1 (but not day 21) was significantly 
higher than that of the control group. However, this effect 
was not dose-dependent. Elevation in lipid peroxidation in 
the hippocampus has been reported at an early time-point 
(e.g., 4 and 24 h) following the administration of KA[32,33]. 
This initial increase of TBARS in the hippocampus has 
been shown to decrease 7 d after status epilepticus, and 
can return to the basal level, but not below it[34]. Further, 
KA administration has been shown to elevate MDA and 
extracellular glutamate, while, decreasing glutathione 
(GSH) levels in the brain[18,22,35]. GSH can act directly as 
an antioxidant[36], and may modulate neurotransmission by 
reacting with neurotransmitters and their binding sites[37]. 
Flavonoids are excellent at scavenging free radicals. Their 
antioxidant activity can be greater than those of vitamins 
C and E[38], and has been attributed to several factors, 
including their physical structure. It is possible that rutin, 
by virtue of its antioxidant properties, is able to scavenge 
free radicals and attenuate oxidative stress. Furthermore, 
the protective effect of rutin on MDA level in the brain 
may have led to the less intense seizures observed in rutin-
treated mice, relative to the control group. 
In this study, we observed that rutin has anticonvulsant 
effects and attenuated oxidative stress in KA-induced 
seizure. Modulatory effects of rutin on GABA receptors 
complex and antioxidant activity are suggested to be two 
possible mechanisms for explaining these results. Further 
studies are needed to find other possible mechanisms.
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